Cryoport (CYRX) Prelim. Q2 Results Miss Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Cryoport (CYRX) Prelim. Q2 Results Miss Consensus

Cryoport Announces Certain Preliminary Results for Second Quarter & Updates 2023 Revenue Expectations

July 12, 2023 4:05 PM EDT

Second quarter results were impacted by weaker than expected global demand for capital equipment; clinical trial start delays; and slower than expected ramps from certain clientsSecond quarter revenue expected in the range of $56.5 - $57.5 millionFull year 2023 revenue now expected in the range of $233 - $243 millionLong-term outlook robust with cell and gene therapy industry expected to grow at a ten-year CAGR in excess of 22%

NASHVILLE,... More